January 9-12, 2017
The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry, bringing together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community.
JPMHC35: Partnering with the Healthcare Industry into the Future
What is today known as the annual J.P. Morgan Healthcare Conference began in 1983 and was hosted by Hambrecht & Quist (H&Q). H&Q was acquired by Chase in 2000 and a year later Chase was acquired by J.P. Morgan. At its infancy, the conference featured just 20 companies, had about 200 attendees and focused on the biotech industry.
Today, while it is still at the Westin St. Francis in San Francisco, the annual J.P. Morgan Healthcare Conference brings thousands of investors from around the world together. The hundreds of companies presenting run the gamut, from start-ups to those with more than $300 billion in market cap, and encompass the entire global healthcare landscape, including pharmaceutical firms, healthcare service providers, profit and not-for-profits, and medical device companies.
Monday, January 9
Jamie Dimon, CEO, JPMorgan Chase & Co.
Tuesday, January 10
Juan Enriquez, Co-Founder, Synthetic Genomics, Inc.; Former Director of the Harvard Business Life Sciences Project; Managing Director, Excel Venture Management
Wednesday, January 11
James Carville, American Political Consultant, Democratic Party, Karl Rove, Former White House Deputy Chief of Staff and American Political Consultant and Policy Advisor, Republican Party
For four days there has been a distinct buzz permeating the streets of San Francisco as the 35th J.P. Morgan Healthcare Conference took over the city. At the Westin St. Francis, clients, investors and company executives learned, networked, discussed and connected.
We’ve heard from more than 300 industry leaders and CEOs highlighting exciting progress in areas such as immuno-oncology and gene therapy, engaged political pundits on what to expect from the new administration, and gained insights from research analysts on where the industry is headed. We had the privilege of hearing from luminaries like Vice President Joe Biden and our own Jamie Dimon.
As the conference comes to a close, we are grateful to all those who helped put this conference together and made it run as smoothly as it did. I have been attending this conference for 17 years and the record-breaking turn out highlights how important the conference is and solidifies J.P. Morgan as the leader in the healthcare space.
J.P. Morgan, Analyst, Healthcare group
Michael Weinstein is J.P. Morgan's senior medical technology analyst and head of the company's healthcare group within Equity Research. He is a 13-time #1 ranked analyst in the annual surveys of both Institutional Investor and Greenwich Associates, and in 2013 was named to the Institutional Investor Hall of Fame.
January 9-12, 2017
The J.P. Morgan Healthcare conference is for clients of the firm, by invitation only. Please reach out to your J.P. Morgan representative to inquire about passes.
Registration closes prior to the conference date. There is no onsite registration.
Yes. Some company presentations will also be available via webcasts.
The agenda is made available only to confirmed attendees.
Yes; there are a limited number of press passes for the event.
All company presentations are considered on-the-record unless otherwise specified. Luncheon keynotes are off-the-record.